|Bid||2.5400 x N/A|
|Ask||2.5600 x N/A|
|Day's Range||2.5200 - 2.6200|
|52 Week Range||2.5200 - 16.7000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for 39YA.DU
The second half of August was tough for the markets but some biotech stocks seemed to have avoided the pain.
BENSENVILLE, IL., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rubicon Technology, Inc. (Nasdaq: RBCN) (“Rubicon” or the “Company”) announced today that, in connection with the cash tender offer (the “Offer”) by Janel Corporation (“Janel”) for up to 45% of Rubicon’s issued and outstanding common stock, par value $.001 per share (“Common Stock”), the Company’s Board of Directors has set August 23, 2022 (the “Record Date”) as the record date for its cash distribution of $11.00 per share of Common Stock (the
In this article we are going to estimate the intrinsic value of Rubicon Technology, Inc. ( NASDAQ:RBCN ) by taking the...